Nipro Corporation is a leading global healthcare company that specializes in medical devices, pharmaceuticals, and pharmaceutical glass products. With a continuous commitment to improving patient outcomes and quality of life, Nipro has built a global network of branches, manufacturing sites, and engineering services.

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells various disposable medical products comprising renal, intervention and anesthesiology, injection and infusion, dialysis, cardiopulmonary, diabetic, and cell cultures products; and sells artificial organ-related products, and generic and kit products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations. The company's Pharma Packaging business offers glass vials, ampoules, syringes, and cartridges; glass tubes; glass forming machinery; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

8086

JP:CO:NIPRO

Nipro Corporation

Last Close

1,382.50

21/11 06:45

Market Cap

210.64B

Beta: -

Volume Today

257.10K

Avg: -

market

industry

website

crunchbase

ipo date

peer of

competitor of

Metrics